Dexmedetomidine
Overview
Dexmedetomidine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL778).
API suppliers (9)
Suppliers of Dexmedetomidine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 8 of 9 suppliers.
4 of 9 hold a GMP certificate on record in the EU or UK registers
- GLAND PHARMA LTDIndia2 active DMF GMP on record
- STERLING WISCONSIN LLC1 active DMF
- YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChina1 active DMF
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina1 active DMF GMP on record
- Emcure Pharmaceuticals LimitedIndia1 active DMF GMP on record
- ASCENSUS SPECIALTIES LLCUnited States1 active DMF
- MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
- HUBEI BIOCAUSE HEILEN PHARMACEUTICAL CO LTDChina1 active DMF
- Orion CorporationFinland
Patent & exclusivity (US)
Per the FDA Orange Book (58 approved US products), the latest listed US patent on Dexmedetomidine expires 12 Jan 2043 and exclusivity 19 Nov 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
- Canonical SMILES
- CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C
- InChIKey
- CUHVIMMYOGQXCV-NSHDSACASA-N
Do you supply Dexmedetomidine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.